New York, NY (PRWEB) January 29, 2013
Dr. Marlene Krauss, managing director of KBL Healthcare Ventures, Inc., an entity that funds innovative healthcare companies, will participate as a panelist in the upcoming Cornell Center for Technology Enterprise & Commercialization (CCTEC) “Mini Boot Camp” on February 27, 2013.
The event, to be held from 3 pm to 6:30 pm at the Weill Greenberg Center at Weill Cornell Medical College at 305 York Avenue in Manhattan, will feature a panel of experts providing advice for new business ventures. Topics include funding and positioning early stage companies as well as the legal aspects of starting a company.
As managing director of KBL Healthcare Ventures, Dr. Krauss has founded and invested in numerous groundbreaking healthcare companies, including Summit Autonomous, Inc., which manufactures the Summit Technology excimer laser, the first laser to be approved by the FDA for refractive eye surgery; now known as LASIK.
Dr. Krauss received a B.A. from Cornell University, an M.B.A. from Harvard Graduate School of Business Administration and an M.D. from Harvard Medical School. She trained at the Harvard affiliated hospitals, the Beth Israel Hospital and the Deaconess Hospital, as well as Mt. Sinai Hospital in New York. She completed her training as a vitreoretinal surgeon at New York Hospital in 1985 and was a Clinical Instructor of Ophthalmology at New York Hospital and is a Board Certified Ophthalmologist.
KBL Healthcare Ventures
KBL Healthcare Ventures is a team of investment professionals with prior experiences as senior executives, clinical practitioners and venture capitalists. The company has funded and invested in dozens of highly successful healthcare industry companies, bringing managerial and technical expertise to emerging companies, while also identifying a path to bring new medical technologies to the public.
Cornell Center for Technology Enterprise & Commercialization
CCTEC is Cornell University's technology transfer office, managing technology for Cornell University, Weill Cornell Medical College and the New York State Agricultural Experiment Station in Geneva. CCTEC support’s Cornell's land-grant and economic development mission and to promote public good by connecting Cornell technologies and plant varieties to industry product and business development efforts. The entity manages inventions from disciplines including veterinary medicine, nanoscale engineering, chemistry, plant breeding, materials science, and medicine. CCTEC licenses Cornell technologies to industry partners throughout the United States, Europe, Asia-Pacific, the Middle East, and Central and South America. Cornell inventions are patented in more than 40 nations.